By Mark E. Neumann
Deceased donor kidneys with the hepatitis C virus can show graft survival beyond 1 year when transplanted into patients without the virus, according to a recently published study.
The study, conducted at two large transplant centers in the U.S., “provides important evidence that HCV-RNA [positive] kidney transplants function well beyond [1] year and that complications, such as rejection and [donor-specific antibodies] DSA, did not occur at elevated rates,” Vishnu Potluri, MD, MPH, of the renal-electrolyte and hypertension division at Perelman School of Medicine at the University of Pennsylvania, and colleagues wrote. Read more in Healio.